Literature DB >> 27852862

Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.

Lauriel F Earley1, John M Powers2, Kei Adachi2, Joshua T Baumgart2, Nancy L Meyer3, Qing Xie3, Michael S Chapman3, Hiroyuki Nakai4,5.   

Abstract

Adeno-associated virus (AAV) vectors have made great progress in their use for gene therapy; however, fundamental aspects of AAV's capsid assembly remain poorly characterized. In this regard, the discovery of assembly-activating protein (AAP) sheds new light on this crucial part of AAV biology and vector production. Previous studies have shown that AAP is essential for assembly; however, how its mechanistic roles in assembly might differ among AAV serotypes remains uncharacterized. Here, we show that biological properties of AAPs and capsid assembly processes are surprisingly distinct among AAV serotypes 1 to 12. In the study, we investigated subcellular localizations and assembly-promoting functions of AAP1 to -12 (i.e., AAPs derived from AAV1 to -12, respectively) and examined the AAP dependence of capsid assembly processes of these 12 serotypes using combinatorial approaches that involved immunofluorescence and transmission electron microscopy, barcode-Seq (i. e., a high-throughput quantitative method using DNA barcodes and a next-generation sequencing technology), and quantitative dot blot assays. This study revealed that AAP1 to -12 are all localized in the nucleus with serotype-specific differential patterns of nucleolar association; AAPs and assembled capsids do not necessarily colocalize; AAPs are promiscuous in promoting capsid assembly of other serotypes, with the exception of AAP4, -5, -11, and -12; assembled AAV5, -8, and -9 capsids are excluded from the nucleolus, in contrast to the nucleolar enrichment of assembled AAV2 capsids; and, surprisingly, AAV4, -5, and -11 capsids are not dependent on AAP for assembly. These observations highlight the serotype-dependent heterogeneity of the capsid assembly process and challenge current notions about the role of AAP and the nucleolus in capsid assembly. IMPORTANCE: Assembly-activating protein (AAP) is a recently discovered adeno-associated virus (AAV) protein that promotes capsid assembly and provides new opportunities for research in assembly. Previous studies on AAV serotype 2 (AAV2) showed that assembly takes place in the nucleolus and is dependent on AAP and that capsids colocalize with AAP in the nucleolus during the assembly process. However, through the investigation of 12 different AAV serotypes (AAV1 to -12), we find that AAP is not an essential requirement for capsid assembly of AAV4, -5, and -11, and AAP, assembled capsids, and the nucleolus do not colocalize for all the serotypes. In addition, we find that there are both serotype-restricted and serotype-promiscuous AAPs in their assembly roles. These findings challenge widely held beliefs about the importance of the nucleolus and AAP in AAV assembly and show the heterogeneous nature of the assembly process within the AAV family.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  adeno-associated virus; assembly-activating protein; capsid assembly; gene therapy; nucleolus; parvovirus

Mesh:

Substances:

Year:  2017        PMID: 27852862      PMCID: PMC5244341          DOI: 10.1128/JVI.01980-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Development of AAV serotype-specific ELISAs using novel monoclonal antibodies.

Authors:  Dirk Kuck; Andrea Kern; Jürgen A Kleinschmidt
Journal:  J Virol Methods       Date:  2006-11-28       Impact factor: 2.014

2.  Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles.

Authors:  Stefanie Stahnke; Kerstin Lux; Silke Uhrig; Florian Kreppel; Marianna Hösel; Oliver Coutelle; Manfred Ogris; Michael Hallek; Hildegard Büning
Journal:  Virology       Date:  2010-10-25       Impact factor: 3.616

3.  A viral assembly factor promotes AAV2 capsid formation in the nucleolus.

Authors:  Florian Sonntag; Kristin Schmidt; Jürgen A Kleinschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 4.  Capsid assembly as a point of intervention for novel anti-viral therapeutics.

Authors:  Vishwanath R Lingappa; Clarence R Hurt; Edward Garvey
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

5.  Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients.

Authors:  André C Carpentier; Frédérique Frisch; Sébastien M Labbé; René Gagnon; Janneke de Wal; Stephen Greentree; Harald Petry; Jaap Twisk; Diane Brisson; Daniel Gaudet
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

6.  Identification and characterization of nuclear and nucleolar localization signals in the adeno-associated virus serotype 2 assembly-activating protein.

Authors:  Lauriel F Earley; Yasuhiro Kawano; Kei Adachi; Xiao-Xin Sun; Mu-Shui Dai; Hiroyuki Nakai
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

7.  Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions.

Authors:  Joyce M Bevington; Patrick G Needham; Kristin C Verrill; Roy F Collaco; Venkatesh Basrur; James P Trempe
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

8.  Subcellular compartmentalization of adeno-associated virus type 2 assembly.

Authors:  A Wistuba; A Kern; S Weger; D Grimm; J A Kleinschmidt
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus.

Authors:  Jarrod S Johnson; R Jude Samulski
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

10.  Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

Authors:  Amit C Nathwani; Ulreke M Reiss; Edward G D Tuddenham; Cecilia Rosales; Pratima Chowdary; Jenny McIntosh; Marco Della Peruta; Elsa Lheriteau; Nishal Patel; Deepak Raj; Anne Riddell; Jun Pie; Savita Rangarajan; David Bevan; Michael Recht; Yu-Min Shen; Kathleen G Halka; Etiena Basner-Tschakarjan; Federico Mingozzi; Katherine A High; James Allay; Mark A Kay; Catherine Y C Ng; Junfang Zhou; Maria Cancio; Christopher L Morton; John T Gray; Deokumar Srivastava; Arthur W Nienhuis; Andrew M Davidoff
Journal:  N Engl J Med       Date:  2014-11-20       Impact factor: 176.079

View more
  30 in total

1.  Establishment of a High-Yield Recombinant Adeno-Associated Virus/Human Bocavirus Vector Production System Independent of Bocavirus Nonstructural Proteins.

Authors:  Ziying Yan; Wei Zou; Zehua Feng; Weiran Shen; Soo Yeun Park; Xuefeng Deng; Jianming Qiu; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2019-01-31       Impact factor: 5.695

2.  Nuclear and Nucleolar Localization of Bovine Adenovirus-3 Protein V.

Authors:  Xin Zhao; Suresh K Tikoo
Journal:  Front Microbiol       Date:  2021-01-06       Impact factor: 5.640

3.  Mapping and Engineering Functional Domains of the Assembly-Activating Protein of Adeno-associated Viruses.

Authors:  Longping V Tse; Sven Moller-Tank; Rita M Meganck; Aravind Asokan
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

Review 4.  Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.

Authors:  Maria Yanqing Chen; Susan S Butler; Weitong Chen; Junghae Suh
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-11-08

5.  Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors.

Authors:  Katja Pekrun; Gustavo De Alencastro; Qing-Jun Luo; Jun Liu; Youngjin Kim; Sean Nygaard; Feorillo Galivo; Feijie Zhang; Ren Song; Matthew R Tiffany; Jianpeng Xu; Matthias Hebrok; Markus Grompe; Mark A Kay
Journal:  JCI Insight       Date:  2019-11-14

6.  Residues on Adeno-associated Virus Capsid Lumen Dictate Interactions and Compatibility with the Assembly-Activating Protein.

Authors:  Anna C Maurer; Ana Karla Cepeda Diaz; Luk H Vandenberghe
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

7.  A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins.

Authors:  John M Powers; Xiao Lan Chang; Zhen Song; Hiroyuki Nakai
Journal:  J Vis Exp       Date:  2018-06-12       Impact factor: 1.355

8.  Site-directed RNA repair of endogenous Mecp2 RNA in neurons.

Authors:  John R Sinnamon; Susan Y Kim; Glen M Corson; Zhen Song; Hiroyuki Nakai; John P Adelman; Gail Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

9.  In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ.

Authors:  David S Ojala; Sabrina Sun; Jorge L Santiago-Ortiz; Mikhail G Shapiro; Philip A Romero; David V Schaffer
Journal:  Mol Ther       Date:  2017-09-08       Impact factor: 11.454

10.  Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.

Authors:  Stefanie Grosse; Magalie Penaud-Budloo; Anne-Kathrin Herrmann; Kathleen Börner; Julia Fakhiri; Vibor Laketa; Chiara Krämer; Ellen Wiedtke; Manuel Gunkel; Lucie Ménard; Eduard Ayuso; Dirk Grimm
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.